Learn More
MP Biomedicals™ β-Nicotinamide Adenine Dinucleotide, Oxidized, MP Biomedicals™
Shop All MP Biomedicals, Inc ProductsDescription
Many metabolites and enzymes of biological interest are present in tissues at low concentrations. With the use of β-NAD as a catalyst intermediate and several enzymes in a multistep system, known as enzyme cycling, much greater sensitivity for detection of these components is achieved. The reduced form, β-NADH, is fluorescent whereas β-NAD is not. This difference in fluorescence provides a sensitive fluorescent measurement of the oxidized or reduced pyridine nucleotides at concentrations down to 10-7 M.
- Serves as a coenzyme of the dehydrogenases, especially in the dehydrogenation of primary and secondary alcohols
- NAD usually acts as an electron acceptor, acting as a carrier for hydride ion, forming b-NADH which then serves as a hydrogen donor in the respiratory chain
- Hydride ion is enzymatically removed from a substrate molecule by the action of dehydrogenases such as malic dehydrogenase and lactic dehydrogenase
- Such enzymes catalyze the reversible transfer of a hydride ion from malate or lactate to b-NAD to form the reduced product, b-NADH
- Unlike b-NAD which has no absorbance at 340nm, b-NADH absorbs at 340nm (EmM = 6.22)
- The increase in absorbance at 340nm with the formation of b-NADH is the basis for measurement of activity of many enzymes

Specifications
Specifications
Color | White |
Purity | ≥99% |
pH | 2 to 4 (1% aq soln) |
Content And Storage | -20°C, Store Desiccated |
Quantity | 100 mg |
Molecular Weight (g/mol) | 663.4 (anhyd.) |
Form | Powder |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.